Published in J Gen Intern Med on February 26, 2010
United States private-sector physicians and pharmaceutical contract research: a qualitative study. PLoS Med (2012) 0.97
Exploring the Potential for Moral Hazard When Clinical Trial Research is Conducted in Rural Communities: Do Traditional Ethics Concepts Apply? HEC Forum (2015) 0.82
What adolescents enrolled in genomic addiction research want to know about conflicts of interest. Drug Alcohol Depend (2014) 0.80
Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional study. PLoS Med (2014) 0.78
Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08
A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med (2000) 3.96
Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research. Acad Med (2003) 3.25
Policies on faculty conflicts of interest at US universities. JAMA (2000) 3.16
Conflict-of-interest policies for investigators in clinical trials. N Engl J Med (2000) 2.69
Conflicts of interest in biomedical research. JAMA (2000) 2.41
Patients' views on financial conflicts of interest in cancer research trials. N Engl J Med (2006) 2.29
Implementation of financial disclosure policies to manage conflicts of interest. Health Aff (Millwood) (2004) 1.86
Community hospital oversight of clinical investigators' financial relationships. IRB (2009) 1.51
Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants. Acad Med (2006) 1.43
Disclosing conflicts of interest in clinical research: views of institutional review boards, conflict of interest committees, and investigators. J Law Med Ethics (2006) 1.19
Comparison of conflict of interest policies and reported practices in academic medical centers in the United States. Account Res (2007) 1.03
The human subjects trade: ethical and legal issues surrounding recruitment incentives. J Law Med Ethics (2003) 0.95
The limitations of "vulnerability" as a protection for human research participants. Am J Bioeth (2004) 14.06
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Patients' views on identifiability of samples and informed consent for genetic research. Am J Bioeth (2008) 5.73
Dealing with the long-term social implications of research. Am J Bioeth (2011) 5.41
Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol (2008) 5.24
Ethics and best practice guidelines for training experiences in global health. Am J Trop Med Hyg (2010) 5.05
Medical and nursing students' television viewing habits: potential implications for bioethics. Am J Bioeth (2008) 4.94
Risks of mortality, myocardial infarction, bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol (2010) 4.50
A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. N Engl J Med (2002) 4.42
Measuring patients' trust in physicians when assessing quality of care. Health Aff (Millwood) (2004) 3.92
Toward a 21st-century health care system: recommendations for health care reform. Ann Intern Med (2009) 3.85
Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA (2007) 3.79
Inappropriate prescribing for elderly Americans in a large outpatient population. Arch Intern Med (2004) 3.64
Oversight of human participants research: identifying problems to evaluate reform proposals. Ann Intern Med (2004) 3.58
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Ethical goals of community consultation in research. Am J Public Health (2005) 3.46
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34
Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol (2003) 3.31
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation (2009) 3.18
The cost of institutional review boards in academic medical centers. N Engl J Med (2005) 3.06
Bioethics consultation in the private sector. Hastings Cent Rep (2002) 3.01
Cost of cancer care: issues and implications. J Clin Oncol (2007) 3.00
Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries. JAMA (2008) 2.96
Characteristics of oncology clinical trials: insights from a systematic analysis of ClinicalTrials.gov. JAMA Intern Med (2013) 2.86
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA (2007) 2.75
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003. J Clin Oncol (2012) 2.72
The inescapable relevance of bioethics for the practicing clinician. Chest (2006) 2.70
Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA (2010) 2.68
Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med (2008) 2.65
New ISSCR guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell (2008) 2.61
Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol (2009) 2.58
Protecting research subjects under the waiver of informed consent for emergency research: experiences with efforts to inform the community. Ann Emerg Med (2003) 2.56
Patient and implanting physician factors associated with mortality and complications after implantable cardioverter-defibrillator implantation, 2002-2005. Circ Arrhythm Electrophysiol (2008) 2.55
Ethical considerations for short-term experiences by trainees in global health. JAMA (2008) 2.48
Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood (2004) 2.30
Resource use in the last 6 months of life among medicare beneficiaries with heart failure, 2000-2007. Arch Intern Med (2010) 2.28
Economic return of clinical trials performed under the pediatric exclusivity program. JAMA (2007) 2.28
Relationship between patient satisfaction with inpatient care and hospital readmission within 30 days. Am J Manag Care (2011) 2.27
Perceived discrimination and reported delay of pharmacy prescriptions and medical tests. J Gen Intern Med (2005) 2.25
Changing gender prevalence of stone disease. J Urol (2007) 2.25
Development of abbreviated measures to assess patient trust in a physician, a health insurer, and the medical profession. BMC Health Serv Res (2005) 2.18
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol (2009) 2.14
Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation (2009) 2.11
Geographic variation in carotid revascularization among Medicare beneficiaries, 2003-2006. Arch Intern Med (2010) 2.08
Urinary diversion in patients with spinal cord injury in the United States. Urology (2012) 2.03
The Presidential Bioethics Commission's database of human subjects research. IRB (2013) 1.98
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail (2009) 1.95
Promoting quality: the health-care organization from a management perspective. Int J Qual Health Care (2007) 1.94
Universal antiretroviral therapy for HIV infection: should US treatment guidelines be applied to resource-limited settings? Clin Infect Dis (2013) 1.92
Development of a scale to measure patients' trust in health insurers. Health Serv Res (2002) 1.91
Patient satisfaction and its relationship with clinical quality and inpatient mortality in acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2010) 1.88
Early and long-term outcomes of heart failure in elderly persons, 2001-2005. Arch Intern Med (2008) 1.88
Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis. Arthritis Rheum (2003) 1.86
Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. J Urol (2004) 1.85
The OHRP and SUPPORT. N Engl J Med (2013) 1.78
Trust and satisfaction with physicians, insurers, and the medical profession. Med Care (2003) 1.77
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state. Blood (2010) 1.76
Medicine. A portfolio model of drug development for tuberculosis. Science (2006) 1.75
Use of larger versus smaller drug-safety databases before regulatory approval: the trade-offs. Health Aff (Millwood) (2008) 1.74
Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol (2008) 1.72
Metaanalysis and review of heart failure disease management randomized controlled clinical trials. Am Heart J (2005) 1.71
Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology (2008) 1.71
Ethics in human subjects research: do incentives matter? J Med Philos (2004) 1.70
Reducing the costs of phase III cardiovascular clinical trials. Am Heart J (2005) 1.69
Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol (2005) 1.69
Measuring trust in medical researchers. Med Care (2006) 1.69
Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia. J Urol (2006) 1.67
The effect of dementia on outcomes and process of care for Medicare beneficiaries admitted with acute myocardial infarction. J Am Geriatr Soc (2004) 1.66
Prostate-specific antigen screening among young men in the United States. Cancer (2008) 1.66
The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer (2003) 1.65
Study of the media's potential influence on prospective research participants' understanding of and motivations for participation in a high-profile phase I trial. J Clin Oncol (2002) 1.64
Gene selection from microarray data for cancer classification--a machine learning approach. Comput Biol Chem (2005) 1.64
What patients say about medical research. IRB (1999) 1.63
Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure. J Gen Intern Med (2006) 1.63
Do patients treated with dignity report higher satisfaction, adherence, and receipt of preventive care? Ann Fam Med (2005) 1.62
Back to the rough ground: working in international HIV prevention as ethical debates continue. IRB (2003) 1.62
Process of care performance measures and long-term outcomes in patients hospitalized with heart failure. Med Care (2010) 1.62
Pseudoporphyria as a result of voriconazole use: a case report. Int J Dermatol (2004) 1.61
Regionalization of percutaneous transluminal coronary angioplasty and implications for patient travel distance. JAMA (2004) 1.59
Attitudes of African American and low socioeconomic status white women toward medical research. J Health Care Poor Underserved (2007) 1.58
Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology (2005) 1.58
In vivo fate-tracing studies using the Scl stem cell enhancer: embryonic hematopoietic stem cells significantly contribute to adult hematopoiesis. Blood (2004) 1.58
Medical costs of abnormal serum sodium levels. J Am Soc Nephrol (2008) 1.56
Permission and assent for clinical research in pediatric anesthesia. Anesth Analg (2002) 1.56
A multinational review of recent trends and reports in dementia caregiver burden. Alzheimer Dis Assoc Disord (2004) 1.55
The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail (2004) 1.54
Ethical and practical issues associated with aggregating databases. PLoS Med (2008) 1.53
How patients' trust relates to their involvement in medical care. J Fam Pract (2005) 1.53
Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study. Pharmacoepidemiol Drug Saf (2005) 1.52
State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction. J Am Coll Cardiol (2004) 1.52
Community hospital oversight of clinical investigators' financial relationships. IRB (2009) 1.51